Charlotte's Web Holdings (CWBHF) Non Operating Investment Income (2023)
Charlotte's Web Holdings' (CWBHF) quarterly Non Operating Investment Income came in at $10.7 million in Q2 2023.
Charlotte's Web Holdings (CWBHF) Non Operating Investment Income (2023) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 1 years of Non Operating Investment Income data on file, last reported at $10.7 million in Q2 2023.
- On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to $10.7 million in Q2 2023; TTM through Jun 2024 was $10.7 million, a 0.0% change from a year earlier, with the FY2023 full-year figure at $10.7 million, changed N/A from the prior year.
- Non Operating Investment Income for Q2 2023 stood at $10.7 million.
- Over the last five years, Non Operating Investment Income for CWBHF reached as high as $10.7 million in Q2 2023 and fell as low as $10.7 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 10.70 Mn |
| Jun 30, 2023 | 10.70 Mn |